Your browser doesn't support javascript.
loading
Monoaminergic impairment in Down syndrome with Alzheimer's disease compared to early-onset Alzheimer's disease.
Dekker, Alain D; Vermeiren, Yannick; Carmona-Iragui, Maria; Benejam, Bessy; Videla, Laura; Gelpi, Ellen; Aerts, Tony; Van Dam, Debby; Fernández, Susana; Lleó, Alberto; Videla, Sebastian; Sieben, Anne; Martin, Jean-Jacques; Blesa, Rafael; Fortea, Juan; De Deyn, Peter P.
Afiliação
  • Dekker AD; Department of Neurology and Alzheimer Research Center, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
  • Vermeiren Y; Laboratory of Neurochemistry and Behaviour, Institute Born-Bunge, University of Antwerp, Wilrijk, Antwerp, Belgium.
  • Carmona-Iragui M; Department of Neurology and Alzheimer Research Center, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
  • Benejam B; Laboratory of Neurochemistry and Behaviour, Institute Born-Bunge, University of Antwerp, Wilrijk, Antwerp, Belgium.
  • Videla L; Department of Neurology, Hospital de la Santa Creu i Sant Pau, Biomedical Research Institute Sant Pau, Universitat Autonoma de Barcelona, Barcelona, Spain.
  • Gelpi E; Down Medical Center, Catalan Down Syndrome Foundation, Barcelona, Spain.
  • Aerts T; Down Medical Center, Catalan Down Syndrome Foundation, Barcelona, Spain.
  • Van Dam D; Down Medical Center, Catalan Down Syndrome Foundation, Barcelona, Spain.
  • Fernández S; Neurological Tissue Bank-Biobanc, Hospital Clinic Barcelona, Institut d'Investigacions Biomediques August Pi i Sunyer, Barcelona, Spain.
  • Lleó A; Laboratory of Neurochemistry and Behaviour, Institute Born-Bunge, University of Antwerp, Wilrijk, Antwerp, Belgium.
  • Videla S; Department of Neurology and Alzheimer Research Center, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
  • Sieben A; Laboratory of Neurochemistry and Behaviour, Institute Born-Bunge, University of Antwerp, Wilrijk, Antwerp, Belgium.
  • Martin JJ; Down Medical Center, Catalan Down Syndrome Foundation, Barcelona, Spain.
  • Blesa R; Down Medical Center, Catalan Down Syndrome Foundation, Barcelona, Spain.
  • Fortea J; Faculty of Health and Life Sciences, Department of Experimental and Health Sciences, Universitat Pompeu Fabra, Barcelona, Spain.
  • De Deyn PP; Laboratory of Neurochemistry and Behaviour, Institute Born-Bunge, University of Antwerp, Wilrijk, Antwerp, Belgium.
Alzheimers Dement (Amst) ; 10: 99-111, 2018.
Article em En | MEDLINE | ID: mdl-29780859

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Alzheimers Dement (Amst) Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Holanda País de publicação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Alzheimers Dement (Amst) Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Holanda País de publicação: Estados Unidos